![Caroline Staib](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Staib joined Genelux Corp.
in 2006 and currently serves as Vice President of Product Development.
Prior to Genelux, she was Head of the Research Group at the Institute of Virology at the Technical University of Munich for eight years.
Dr. Staib received a PhD in Biochemistry and Human Genetics as well as a Master's degree in Biochemistry, Microbiology, and Animal Physiology from the University of Würzburg.
| Unternehmen | Position | Ende |
|---|---|---|
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| GENELUX CORPORATION | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
